These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy. Ali F; Martin PR; Botha H; Ahlskog JE; Bower JH; Masumoto JY; Maraganore D; Hassan A; Eggers S; Boeve BF; Knopman DS; Drubach D; Petersen RC; Dunkley ED; van Gerpen J; Uitti R; Whitwell JL; Dickson DW; Josephs KA Mov Disord; 2019 Aug; 34(8):1144-1153. PubMed ID: 30726566 [TBL] [Abstract][Full Text] [Related]
4. Accuracy of the National Institute for Neurological Disorders and Stroke/Society for Progressive Supranuclear Palsy and neuroprotection and natural history in Parkinson plus syndromes criteria for the diagnosis of progressive supranuclear palsy. Respondek G; Roeber S; Kretzschmar H; Troakes C; Al-Sarraj S; Gelpi E; Gaig C; Chiu WZ; van Swieten JC; Oertel WH; Höglinger GU Mov Disord; 2013 Apr; 28(4):504-9. PubMed ID: 23436751 [TBL] [Abstract][Full Text] [Related]
5. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Litvan I; Agid Y; Calne D; Campbell G; Dubois B; Duvoisin RC; Goetz CG; Golbe LI; Grafman J; Growdon JH; Hallett M; Jankovic J; Quinn NP; Tolosa E; Zee DS Neurology; 1996 Jul; 47(1):1-9. PubMed ID: 8710059 [TBL] [Abstract][Full Text] [Related]
6. An autopsy-confirmed case of progressive supranuclear palsy with predominant postural instability. Kurz C; Ebersbach G; Respondek G; Giese A; Arzberger T; Höglinger GU Acta Neuropathol Commun; 2016 Nov; 4(1):120. PubMed ID: 27842578 [TBL] [Abstract][Full Text] [Related]
7. Pyramidal system involvement in progressive supranuclear palsy - a clinicopathological correlation. Stejskalova Z; Rohan Z; Rusina R; Tesar A; Kukal J; Kovacs GG; Bartos A; Matej R BMC Neurol; 2019 Mar; 19(1):42. PubMed ID: 30894142 [TBL] [Abstract][Full Text] [Related]
8. Are the International Parkinson disease and Movement Disorder Society progressive supranuclear palsy (IPMDS-PSP) diagnostic criteria accurate enough to differentiate common PSP phenotypes? Shoeibi A; Litvan I; Juncos JL; Bordelon Y; Riley D; Standaert D; Reich SG; Shprecher D; Hall D; Marras C; Kluger B; Olfati N; Jankovic J Parkinsonism Relat Disord; 2019 Dec; 69():34-39. PubMed ID: 31665686 [TBL] [Abstract][Full Text] [Related]
11. Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be? Whitwell JL; Höglinger GU; Antonini A; Bordelon Y; Boxer AL; Colosimo C; van Eimeren T; Golbe LI; Kassubek J; Kurz C; Litvan I; Pantelyat A; Rabinovici G; Respondek G; Rominger A; Rowe JB; Stamelou M; Josephs KA; Mov Disord; 2017 Jul; 32(7):955-971. PubMed ID: 28500751 [TBL] [Abstract][Full Text] [Related]
12. Video-tutorial for the Movement Disorder Society criteria for progressive supranuclear palsy. Iankova V; Respondek G; Saranza G; Painous C; Cámara A; Compta Y; Aiba I; Balint B; Giagkou N; Josephs KA; Otsuki M; Golbe LI; Bhatia KP; Stamelou M; Lang AE; Höglinger GU; Parkinsonism Relat Disord; 2020 Sep; 78():200-203. PubMed ID: 32988736 [TBL] [Abstract][Full Text] [Related]